121 related articles for article (PubMed ID: 10964677)
1. Evaluation of dipeptide alpha-keto-beta-aldehydes as new inhibitors of cathepsin S.
Walker B; Lynas JF; Meighan MA; Brömme D
Biochem Biophys Res Commun; 2000 Aug; 275(2):401-5. PubMed ID: 10964677
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the P2-P3 SAR of aldehyde cathepsin K inhibitors.
Boros EE; Deaton DN; Hassell AM; McFadyen RB; Miller AB; Miller LR; Paulick MG; Shewchuk LM; Thompson JB; Willard DH; Wright LL
Bioorg Med Chem Lett; 2004 Jul; 14(13):3425-9. PubMed ID: 15177446
[TBL] [Abstract][Full Text] [Related]
3. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
Lynas JF; Hawthorne SJ; Walker B
Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
[TBL] [Abstract][Full Text] [Related]
4. Keto-1,3,4-oxadiazoles as cathepsin K inhibitors.
Palmer JT; Hirschbein BL; Cheung H; McCarter J; Janc JW; Yu ZW; Wesolowski G
Bioorg Med Chem Lett; 2006 Jun; 16(11):2909-14. PubMed ID: 16546382
[TBL] [Abstract][Full Text] [Related]
5. Selective nitrile inhibitors to modulate the proteolytic synergism of cathepsins S and F.
Frizler M; Schmitz J; Schulz-Fincke AC; Gütschow M
J Med Chem; 2012 Jun; 55(12):5982-6. PubMed ID: 22686657
[TBL] [Abstract][Full Text] [Related]
6. Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.
Black WC; Bayly CI; Davis DE; Desmarais S; Falgueyret JP; Léger S; Li CS; Massé F; McKay DJ; Palmer JT; Percival MD; Robichaud J; Tsou N; Zamboni R
Bioorg Med Chem Lett; 2005 Nov; 15(21):4741-4. PubMed ID: 16154747
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide nitrile inhibitors of cathepsin K.
Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Lattmann R; Missbach M
Bioorg Med Chem Lett; 2006 May; 16(9):2549-54. PubMed ID: 16480867
[TBL] [Abstract][Full Text] [Related]
8. Specificity determinants of human cathepsin s revealed by crystal structures of complexes.
Pauly TA; Sulea T; Ammirati M; Sivaraman J; Danley DE; Griffor MC; Kamath AV; Wang IK; Laird ER; Seddon AP; Ménard R; Cygler M; Rath VL
Biochemistry; 2003 Mar; 42(11):3203-13. PubMed ID: 12641451
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
[TBL] [Abstract][Full Text] [Related]
10. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells.
Montaser M; Lalmanach G; Mach L
Biol Chem; 2002; 383(7-8):1305-8. PubMed ID: 12437121
[TBL] [Abstract][Full Text] [Related]
11. Paecilopeptin, a new cathepsin S inhibitor produced by Paecilomyces carneus.
Shindo K; Suzuki H; Okuda T
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2444-8. PubMed ID: 12506985
[TBL] [Abstract][Full Text] [Related]
12. Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.
Catalano JG; Deaton DN; Furfine ES; Hassell AM; McFadyen RB; Miller AB; Miller LR; Shewchuk LM; Willard DH; Wright LL
Bioorg Med Chem Lett; 2004 Jan; 14(1):275-8. PubMed ID: 14684342
[TBL] [Abstract][Full Text] [Related]
13. Natural biflavones as novel inhibitors of cathepsin B and K.
Zeng GZ; Pan XL; Tan NH; Xiong J; Zhang YM
Eur J Med Chem; 2006 Nov; 41(11):1247-52. PubMed ID: 16828525
[TBL] [Abstract][Full Text] [Related]
14. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
[TBL] [Abstract][Full Text] [Related]
15. New potent cathepsin G phosphonate inhibitors.
Sieńczyk M; Lesner A; Wysocka M; Legowska A; Pietrusewicz E; Rolka K; Oleksyszyn J
Bioorg Med Chem; 2008 Oct; 16(19):8863-7. PubMed ID: 18805698
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
Chatterjee AK; Liu H; Tully DC; Guo J; Epple R; Russo R; Williams J; Roberts M; Tuntland T; Chang J; Gordon P; Hollenbeck T; Tumanut C; Li J; Harris JL
Bioorg Med Chem Lett; 2007 May; 17(10):2899-903. PubMed ID: 17382545
[TBL] [Abstract][Full Text] [Related]
17. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.
Ayesa S; Lindquist C; Agback T; Benkestock K; Classon B; Henderson I; Hewitt E; Jansson K; Kallin A; Sheppard D; Samuelsson B
Bioorg Med Chem; 2009 Feb; 17(3):1307-24. PubMed ID: 19124252
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption.
Yasuma T; Oi S; Choh N; Nomura T; Furuyama N; Nishimura A; Fujisawa Y; Sohda T
J Med Chem; 1998 Oct; 41(22):4301-8. PubMed ID: 9784105
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools.
Desmarais S; Massé F; Percival MD
Biol Chem; 2009 Sep; 390(9):941-8. PubMed ID: 19453281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
